🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

💻How digitally mature is your organization? The second blog in our Polar Control series, authored by Unjulie Bhanot, discusses how a process-focused digital solution enables scientists to evaluate a parameter’s impact. 🏅Read more: ow.ly/HmsZ50VT8tM #IDBSPolarControl

Our recent market survey asked #BioPharma scientists to share their key considerations for platform purchases.* What do you think is the most important factor? Comment below. *N = 856 respondents using scientific lab data platforms, IDBS Market Research Study, 2025.

Ease of use and intuitiveness was selected as the most important aspect of a scientific laboratory data platform interface.* See other key aspects: ow.ly/9XvM50VPmj1 *N = 856 respondents using scientific lab data platforms, IDBS Market Research Study, 2025.

💊The average cost to develop new drugs hit $2.23 billion in 2024. A report from Deloitte analyzed the late-stage development pipelines of the top 20 #biopharma companies. Results showed that last year 12 companies saw higher R&D costs. Read more: ow.ly/NOyY50VZRC2

📈According to Harvard Business Review, average US tariffs are approaching 23%. With lab budgets already tight, #Biopharma companies should make the most of existing equipment. 🤝IDBS Polar Insight allows you to monitor calibration and maintenance: ow.ly/3qwP50VT7RT

📈The global market size for #AI in drug development is forecast to hit $7.8 billion by 2032. In our Polar Control blog-series, Unjulie Bhanot shares how process-focused digital tools help provide comprehensive datasets for AI tools: ow.ly/ZbIe50VT8It #IDBSPolarControl

Are you facing challenges in maintaining GxP compliance while embracing digital transformation? Join us for an expert-led webinar that explores how to reduce compliance burdens and mitigate risk without slowing innovation. Watch now - ow.ly/JxMo50W1s0V #GxP #compliance

🚨 Breaking News: Eisai & KBI Biopharma Join i3 Europe 2025 Lineup! 🚨 🔗 Register now to secure your spot and be part of the conversation shaping the future of R&D: ow.ly/abhw50W4HNi #i3Europe2025 #LifeSciences #IDBS #Eisai #KBIBiopharma #Automation #DataStrategy

How have you responded to the new US tariffs? An article from NSF outlines the potential impact of the new tariffs on the life science industry and suggests how companies can stay ahead of future changes: ow.ly/HhL750W4Ikx #lifesciences #digitaltransformation

Data integrity is key for regulatory compliance, product quality and patient safety. Yet, many organizations face challenges maintaining accurate, complete and consistent records. Join our webinar to learn how to navigate GxP compliance with confidence: ow.ly/hmkG50W1s5g

🔓Unlock data integrity and learn proven strategies for GxP compliance and inspection readiness Join Jim Brooks and Kurt In Albon for our webinar in partnership with Pharmaceutical Online on June 23rd: ow.ly/qboB50W4Itb #dataintegrity #lifesciences #compliance

💰According to the European Commission and PWC, data that does not adhere to FAIR principles costs the European economy €10.2 billion annually. By maintaining accurate data, #BioPharma companies can prevent errors and ensure compliance. Learn more: ow.ly/lZKb50W5vh6

🚀 The countdown to i3 Europe 2025 is officially on! If you're passionate about shaping the future of R&D and digital transformation, this is your moment. 🎟️ Don’t miss out: ow.ly/fTC950W4HUN #i3Europe2025 #LifeSciences #DigitalTransformation #NetworkingOpportunity

🔬AI-discovered molecules in Phase I clinical trials show a success rate of 80-90%. By 2030, Deloitte predicts AI will be central to optimizing trial design, generating drug performance insights and automating reporting: ow.ly/1M0H50W4PAt #drugdevelopment #labofthefuture

⌚Reduce QA study time for bioanalysis by 75% with IDBS Polar.* The BioA Study Report enables CROs and sponsors to improve the quality of preclinical and clinical assays by digitizing study planning. 📺Watch our product demos: ow.ly/vy6e50W37VK *Data on file at IDBS.

The i3 User Group Meeting is back – and we want you to be part of it! Join a vibrant community of innovators and industry leaders and have the opportunity to present a poster that showcases your journey with #IDBS solutions. Register: ow.ly/BI9650W8UsE #i3Europe2025

🔍 Why are companies still receiving warning letters on data integrity? Data integrity issues continue to surface across industries underscoring the need for a robust data integrity framework. 📢 Join our Webinar to learn more: ow.ly/pSR850W9Ryi #GxP #dataintegrity

⚡ Ready to supercharge your workflows? Join us at i3 2025 for a session with IDBS' Nick Fuller, Sylvia Muller, and Matthew Kennedy where they will explore the art of building efficient and user-friendly workflows in the IDBS platform: ow.ly/lGM350Wc6IV #i3Europe2025

Join IDBS at Bio-Expo Live next week! We'll be exploring how IDBS Polar enables high-quality, compliant data workflows, empowering teams to streamline development and accelerate bioprocess innovation. Register Now - ow.ly/xE1T50Wc77Q #BioExpoLive #Bioprocessing

🤔Is your data #AI ready? In a recent Drug Discovery & Development article, Stuart Ward explains that complete and contextualized data is crucial for #AI adoption to be successful. Read the article for Stuart's top tips: ow.ly/bCBV50W9Ruz #DanaherNews